iShares Core US Aggregate Bond ETF vs 22nd Century Group Inc — how do they compare? iShares Core US Aggregate Bond ETF trades at $97.51, while 22nd Century Group Inc trades at $4.46 (market cap $1.52M). Which is the better fit depends on your goals.
| AGG | XXII | |
|---|---|---|
Sector | Fixed Income | Technology |
52-Week High | $101.40 | $801.00 |
52-Week Low | $97.24 | $3.72 |
Market Cap | — | $1.52M |
Enterprise Value | — | -$6.71M |
Signals from Pluang's Aura AI — not financial advice
AGG trades at $97.505, up 0.27% on the day, with a bearish technical signal from moving averages and neutral oscillators. Recent news highlights institutional activity, including Bay Colony Advisory reducing holdings and First Bank & Trust increasing its stake. Bond ETF flows remain strong, with $300 billion in H1 2026 inflows, but rising Treasury yields and inflation concerns pressure fixed-income assets.
The outlook is cautious due to bearish technicals and macroeconomic headwinds like higher yields and oil prices. Risks include Fed rate hike expectations and Middle East tensions, but AGG offers steady dividends and remains a core holding for income-focused portfolios amid market volatility.
XXII trades at $4.46, up 2.53% today, with a neutral technical signal and bearish moving averages. The company shows deep losses with a net income margin of -65.76% and negative ROE of -130.19%, though it beat earnings in Q3 2025. Recent news highlights VLN® retail expansion in California and New York, and a reverse stock split on June 12, 2026. Cash flow remains dependent on financing, with operating cash flow negative at -$7.72 million in 2025.
Outlook is speculative; analyst consensus is 75% buy with growth potential from VLN® market expansion, but high execution and regulatory risks persist. Investment hinges on revenue scaling to offset persistent losses, with stock volatility expected near key resistance at $5.
Trailing returns across standard periods
AGG tracks the Bloomberg U.S. Aggregate Bond Index, providing broad exposure to the total U.S. investment-grade bond market. It serves as a core portfolio building block by diversifying across Treasuries, government-related bonds, corporate debt, and mortgage-backed securities.
Read more on AGG →22nd Century Group is a plant biotechnology company that uses genetic engineering and gene editing to control the levels of nicotine in tobacco plants. Its flagship product line, VLN®, is the first and only combustible cigarette authorized by the FDA as a Modified Risk Tobacco Product (MRTP), containing 95% less nicotine than traditional cigarettes to help adult smokers smoke less.
Read more on XXII →